Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) have been in agreement on a lot since the beginning of the pandemic. They both recognized the importance of eventually launching combined vaccines -- such as those covering flu and coronavirus -- and consider them the ticket to stronger vaccine uptake. The vaccine leaders also have predicted the coronavirus vaccine market is likely to follow that of the flu market, with many Americans going for an annual jab.